CRL
Charles River Laboratories International Inc.

909
Loading...
Loading...
Upcoming Earnings: Q3 '25
Reports: Nov 05,
Pre-Market

Estimated EPS

$2.35

Estimated Rev

$982.16M

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '25
$2.35
--
--
N/A
Q2 '25
$2.50
$3.12
24.69%
BEAT
Q1 '25
$2.07
$2.34
12.79%
BEAT
Q4 '24
$2.53
$2.66
5.24%
BEAT
Q3 '24
$2.42
$2.59
6.91%
BEAT

Latest CRL News

View

Advertisement. Remove ads.

Advertisement. Remove ads.